Chapter/Section Purchase

1 Study Coverage
1.1 Recombinant Human Granulocyte Colony-Stimulating Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lenograstim (Granocyte)
1.2.3 Filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim)
1.2.4 Others
1.3 Market by Application
1.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Chemotherapy Induced Neutropenia
1.3.3 Before Blood Donation
1.3.4 Stem Cell Transplants
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region
2.4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Human Granulocyte Colony-Stimulating by Region (2023-2028)
2.5 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region
2.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2022)
2.5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Manufacturers
3.1.1 Global Top Recombinant Human Granulocyte Colony-Stimulating Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Human Granulocyte Colony-Stimulating in 2021
3.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers
3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Human Granulocyte Colony-Stimulating Revenue in 2021
3.3 Global Recombinant Human Granulocyte Colony-Stimulating Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Human Granulocyte Colony-Stimulating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Human Granulocyte Colony-Stimulating Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Type
4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Type
4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type
4.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Price by Type (2017-2022)
4.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Human Granulocyte Colony-Stimulating Sales by Application
5.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Human Granulocyte Colony-Stimulating Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Human Granulocyte Colony-Stimulating Revenue by Application
5.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Human Granulocyte Colony-Stimulating Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application
5.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Price by Application (2017-2022)
5.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
6.1.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028)
6.1.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2028)
6.2 North America Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
6.2.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028)
6.2.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2028)
6.3 North America Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
6.3.1 North America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2028)
6.3.2 North America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028)
7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2028)
7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
7.2.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028)
7.2.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2028)
7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
7.3.1 Europe Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2028)
7.3.2 Europe Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
8.1.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
8.2.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Market Size by Region
8.3.1 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
9.1.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2028)
9.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
9.2.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2028)
9.3 Latin America Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
9.3.1 Latin America Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size by Type
10.1.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size by Application
10.2.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Market Size by Country
10.3.1 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Human Granulocyte Colony-Stimulating Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Overview
11.1.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Corporation Information
11.2.2 Qilu Pharmaceutical Overview
11.2.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Qilu Pharmaceutical Recent Developments
11.3 Shijiazhuang Pharmaceutical
11.3.1 Shijiazhuang Pharmaceutical Corporation Information
11.3.2 Shijiazhuang Pharmaceutical Overview
11.3.3 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Shijiazhuang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Shijiazhuang Pharmaceutical Recent Developments
11.4 Kyowa Hakko Kirin
11.4.1 Kyowa Hakko Kirin Corporation Information
11.4.2 Kyowa Hakko Kirin Overview
11.4.3 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kyowa Hakko Kirin Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kyowa Hakko Kirin Recent Developments
11.5 Gensci
11.5.1 Gensci Corporation Information
11.5.2 Gensci Overview
11.5.3 Gensci Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Gensci Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Gensci Recent Developments
11.6 Amoytop Biotech
11.6.1 Amoytop Biotech Corporation Information
11.6.2 Amoytop Biotech Overview
11.6.3 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Amoytop Biotech Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amoytop Biotech Recent Developments
11.7 Hangzhou Jiuyuan
11.7.1 Hangzhou Jiuyuan Corporation Information
11.7.2 Hangzhou Jiuyuan Overview
11.7.3 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hangzhou Jiuyuan Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hangzhou Jiuyuan Recent Developments
11.8 Huaxin
11.8.1 Huaxin Corporation Information
11.8.2 Huaxin Overview
11.8.3 Huaxin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Huaxin Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Huaxin Recent Developments
11.9 Triprime
11.9.1 Triprime Corporation Information
11.9.2 Triprime Overview
11.9.3 Triprime Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Triprime Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Triprime Recent Developments
11.10 Sinovac
11.10.1 Sinovac Corporation Information
11.10.2 Sinovac Overview
11.10.3 Sinovac Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sinovac Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sinovac Recent Developments
11.11 Zhaoke
11.11.1 Zhaoke Corporation Information
11.11.2 Zhaoke Overview
11.11.3 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zhaoke Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zhaoke Recent Developments
11.12 Kawin
11.12.1 Kawin Corporation Information
11.12.2 Kawin Overview
11.12.3 Kawin Recombinant Human Granulocyte Colony-Stimulating Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Kawin Recombinant Human Granulocyte Colony-Stimulating Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Kawin Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Human Granulocyte Colony-Stimulating Industry Chain Analysis
12.2 Recombinant Human Granulocyte Colony-Stimulating Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Human Granulocyte Colony-Stimulating Production Mode & Process
12.4 Recombinant Human Granulocyte Colony-Stimulating Sales and Marketing
12.4.1 Recombinant Human Granulocyte Colony-Stimulating Sales Channels
12.4.2 Recombinant Human Granulocyte Colony-Stimulating Distributors
12.5 Recombinant Human Granulocyte Colony-Stimulating Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Human Granulocyte Colony-Stimulating Industry Trends
13.2 Recombinant Human Granulocyte Colony-Stimulating Market Drivers
13.3 Recombinant Human Granulocyte Colony-Stimulating Market Challenges
13.4 Recombinant Human Granulocyte Colony-Stimulating Market Restraints
14 Key Findings in The Global Recombinant Human Granulocyte Colony-Stimulating Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer